Catching a Killer? Six "Genetic Markers" to Assess Nascent Competitor Acquisitions
External Article
Baker Botts Partner John Taladay and Special Counsel Christine M. Ryu-Naya analyze the acquisition of nascent competitors by larger firms which has sparked intense debate in antitrust policy, particularly in the tech sector, where startups frequently view acquisition as a primary exit strategy. Critics warn of “killer acquisitions,” where potential rivals are neutralized before they can pose a competitive threat.

